Company
Nuronus builds multi-tenant compliance software for MSPs. This page is for investors and strategic partners who want a clear overview and a direct line to the founder.
MSPs are asked to deliver HIPAA, SOC 2, CMMC, cyber insurance, and related readiness across many clients. Enterprise GRC tools were built for one company's internal program. Spreadsheets and ticket screenshots do not scale into a sellable service.
Nuronus is the MSP-shaped alternative: multi-tenant, white-label reports and evidence, framework mapping on a CIS control backbone, and connections to the identity and RMM tools MSPs already run. MSPs can start free for two clients, then grow on flat plans tied to client count.
The company is founder-led and based in Utah. Product decisions stay tied to MSP delivery, not enterprise sales cycles.
A SaaS subscription for MSPs: client workspaces, framework readiness, evidence collection, assessments, and white-label PDF reports. Pricing is public on /pricing.
We do not sell certifications or replace auditors. We help MSPs organize controls, evidence, and client-facing reports so compliance work can be delivered as a service.

Founder & CEO
20+ years in IT infrastructure and security. Built Nuronus after watching MSPs leave compliance revenue on the table because the tooling made it impossible to deliver profitably.
Public pages useful for diligence. We do not publish unaudited financial statements or illustrative model packs on this site.
For investor or strategic partnership inquiries, email the founder directly. Include who you are, your firm (if any), and what you want to discuss.
Brett Coffin
Founder & CEO, Nuronus
Salt Lake City, Utah, USA
This page is informational and is not an offer to sell or a solicitation to buy securities. Any future financing would be conducted under applicable securities laws with qualified parties only.
We use essential cookies to run the site (sign-in, security, language). Analytics and marketing cookies load only if you allow them. See our Cookie Policy and Privacy Policy.